Risk assessment of over-the-counter cannabinoid-based cosmetics: Legal and regulatory issues governing the safety of cannabinoid-based cosmetics in the UAE
Contents
Appearance
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H25NO2 |
Molar mass | 251.370 g·mol−1 |
3D model (JSmol) | |
|
Xibenolol is a beta blocker.[1][2]
References
- ^ "The Use of Common Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances: Alphabetical list of stems together with corresponding INNs". Archived from the original on March 7, 2012.
- ^ Honma S, Ito T, Kambegawa A (February 1985). "Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man". Chemical & Pharmaceutical Bulletin. 33 (2): 760–8. doi:10.1248/cpb.33.760. PMID 2861914.